Related Experiment Video
Updated: Apr 23, 2026

07:36
Modeling Encephalopathy of Prematurity Using Prenatal Hypoxia-ischemia with Intra-amniotic Lipopolysaccharide in Rats
Published on: November 20, 2015
10.5K
Small for gestational age newborns--does pre-recognition make a difference in pregnancy outcome?
Amir Aviram1, Yariv Yogev, Ron Bardin
1a Rabin Medical Center, Helen Schneider Hospital for Women , Petah Tikva , Israel and.
Summary
Pre-recognizing small for gestational age (SGA) in late preterm or term pregnancies may improve neonatal outcomes. However, SGA identification alone does not warrant intervention, which can lead to adverse effects.
Area of Science:
- Obstetrics and Gynecology
- Neonatology
- Fetal Medicine
Background:
- Small for gestational age (SGA) is a significant concern in late preterm and term pregnancies.
- Accurate prenatal identification of SGA is crucial for optimizing pregnancy outcomes.
- Intrauterine growth restriction (IUGR) is a common cause of SGA, necessitating careful monitoring.
Purpose of the Study:
- To evaluate the impact of pre-recognition of small for gestational age (SGA) on pregnancy and neonatal outcomes.
- To determine if suspected IUGR based on sonographic estimated fetal weight (EFW) influences delivery timing and mode.
- To assess the association between suspected SGA and adverse neonatal outcomes.
Main Methods:
- Retrospective analysis of SGA newborns (EFW <10th percentile) and non-SGA controls.
- Stratification of SGA cases into suspected IUGR and unsuspected IUGR groups based on pre-delivery sonography.
- Comparison of delivery characteristics and neonatal outcomes between suspected and unsuspected SGA groups.
Main Results:
- SGA was prenatally diagnosed in only 26% of cases.
- Women with suspected SGA delivered earlier, at lower birth weights, and had higher rates of labor induction and cesarean delivery.
- Suspected SGA was associated with adverse neonatal outcomes, but multivariate analysis indicated that suspected SGA, birthweight, gestational age, and spontaneous vaginal delivery were independently linked to improved composite neonatal outcomes.
Conclusions:
- Prenatal identification of SGA can potentially improve neonatal outcomes.
- SGA diagnosis alone is not an indication for intervention.
- Interventions for SGA without clear indication may lead to adverse pregnancy outcomes.
Related Concept Videos
Pathophysiology of Diabetes
3.9K
Diabetes mellitus is a chronic metabolic disorder characterized by hyperglycemia. The four categories of diabetes are type 1 diabetes, type 2 diabetes, other specific types of diabetes, and gestational diabetes.
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
3.9K
Mitral Valve Prolapse III: Nursing Management
569
The nursing management of Mitral Valve Prolapse, or MVP, centers around patient education, symptom monitoring, and lifestyle modifications.Patient Education on MVP Diagnosis and Heredity: Nurses should provide comprehensive education about MVP, a condition where the mitral valve does not close appropriately during heartbeats. This education often includes the condition's pathophysiology, symptoms, and potential complications, like arrhythmias or mitral regurgitation. Though not fully...
569
Diabetes Mellitus: Type 2 and Gestational
4.8K
Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
4.8K
Teratogenicity
4.2K
The ability of a drug to produce structural deformations and functional abnormalities in the developing embryo or the fetus is called teratogenicity, and the drug producing this effect is known as a teratogen. Teratogenic effects include stillbirth, miscarriage, intrauterine growth restriction, and neurocognitive delay. A teratogen may affect the embryo at different stages of development, which is important in determining the type and extent of the damage. During blastocyst formation, the early...
4.2K

